CORC

浏览/检索结果: 共30条,第1-10条 帮助

限定条件        
已选(0)清除 条数/页:   排序方式:
SHR-A1403, a novel c-mesenchymal-epithelial transition factor (c-Met) antibody-drug conjugate, overcomes AZD9291 resistance in non-small cell lung cancer cells overexpressing c-Met 期刊论文
CANCER SCIENCE, 2019, 页码: 11
作者:  Tong, Mengya;  Gao, Mingzhao;  Xu, Yongping;  Fu, Li;  Li, Yun
收藏  |  浏览/下载:21/0  |  提交时间:2020/07/01
Blocking ROR1 enhances the roles of erlotinib in lung adenocarcinoma cell lines 期刊论文
ONCOLOGY LETTERS, 2019, 卷号: 18, 期号: 3, 页码: 2977-2984
作者:  Wang, Hui-Li;  Liu, Yan-Chun;  Long, Ming-Peng;  Zheng, Chuan;  Yang, Jia-Hui
收藏  |  浏览/下载:95/0  |  提交时间:2019/11/07
Discovery of a novel third generation EGFR TKI and identification of its potential mechanism of resistance 期刊论文
CANCER RESEARCH, 2019, 卷号: 79, 期号: 13, 页码: 2
作者:  Zhang, Tao;  Qu, Rong;  Chen, Chengbin;  Tong, Linjiang;  Feng, Fang
收藏  |  浏览/下载:4/0  |  提交时间:2020/07/01
Discovery and characterization of a novel highly potent and selective type II native and drug-resistant V299L mutant BCR-ABL inhibitor (CHMFL-ABL-039) for Chronic Myeloid Leukemia (CML) 期刊论文
CANCER BIOLOGY & THERAPY, 2019, 卷号: 20, 期号: 6, 页码: 877-885
作者:  Wu, Jiaxin;  Wang, Aoli;  Li, Xixiang;  Chen, Cheng;  Qi, Ziping
收藏  |  浏览/下载:29/0  |  提交时间:2019/11/27
Development and validation of a prognostic index for efficacy evaluation and prognosis of first-line chemotherapy in stage III-IV lung squamous cell carcinoma 期刊论文
EUROPEAN RADIOLOGY, 2019, 卷号: 29, 期号: 5, 页码: 2388-2398
作者:  Song, Jiangdian;  Tian, Jie;  Zhang, Lina;  Qu, Xiujuan;  Qian, Wei
收藏  |  浏览/下载:64/0  |  提交时间:2019/07/12
肺粘液表皮样癌并ALK基因突变1例及文献复习 期刊论文
临床肺科杂志, 2019, 卷号: 24, 期号: 4
作者:  屈贵东;  施云飞
收藏  |  浏览/下载:1/0  |  提交时间:2019/12/04
Successful treatment of a lung adenocarcinoma patient with a novel EGFR exon 20-ins mutation with afatinib A case report 期刊论文
MEDICINE, 2019, 卷号: 98, 期号: 1
作者:  Cai, Yangyang;  Wang, Xu;  Guo, Ye;  Sun, Chao;  Xu, Yinghui
收藏  |  浏览/下载:28/0  |  提交时间:2019/12/05
EGFR-TKI不良反应管理专家共识 期刊论文
中国肺癌杂志, 2019, 期号: 2
作者:  胡洁;  林丽珠;  骆肖群;  茅益民;  周建英
收藏  |  浏览/下载:7/0  |  提交时间:2019/12/05
GLRX inhibition enhances the effects of geftinib in EGFR-TKI-resistant NSCLC cells through FoxM1 signaling pathway 期刊论文
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 卷号: 145, 期号: 4
作者:  Wang, Linlin;  Liu, Jing;  Liu, Jinguo;  Chen, Xiaoyan;  Chang, Meijia
收藏  |  浏览/下载:28/0  |  提交时间:2019/12/05
Cost-Effectiveness of Osimertinib in Treating Newly Diagnosed, Advanced EGFR-Mutation-Positive Non-Small Cell Lung Cancer 期刊论文
ONCOLOGIST, 2019, 卷号: 24, 期号: 3
作者:  Wu, Bin;  Gu, Xiaohua;  Zhang, Qiang;  Xie, Feng
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace